Broadcom Inc. (AVGO)
Quantitative Summary
DeterministicAVGO trades at 86.9x earnings — a 34% premium to its sector average of 65.0x — without a dominant ROIC-WACC spread. Financial health metrics are strong: Piotroski 8/9, Altman Z 12.8 (above 3.0 safe zone threshold). DCF fair value of $109 implies 71% downside based on model assumptions. Beneish M-Score of -1.86 exceeds the -2.22 academic threshold — earnings quality may warrant further review.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of Broadcom Inc. reflect a robust operational engine driven primarily by exceptional margin expansion rather than asset efficiency or leverage. With an ROE of 28.4% decomposed into a net margin of 36.2%, low asset turnover of 0.37x, and moderate equity multipliers, the return profile is clearly margin-led. This high-quality earnings generation is corroborated by superior governance metrics: a Piotroski F-Score of 8/9 signals strong financial health, while an Altman Z-Score of 11.7 and Beneish M-Score of -1.86 indicate minimal distress risk and low manipulation probability. However, the capital allocation efficiency is constrained; despite generating revenue growth of 23.9%, the ROIC-WACC spread narrows to just +1.2%, suggesting that current returns barely exceed the cost of capital once weighted average costs are accounted for.
Valuation metrics present a significant divergence between market pricing and intrinsic value models. Trading at a forward P/E of 61.3x, which substantially exceeds the sector average of 42.2x, the stock commands a premium consistent with its growth trajectory but appears fully priced or overvalued relative to fundamentals. A discounted cash flow analysis implies a fair value significantly lower than current levels, reflecting an embedded expectation for ten-year free cash flow growth exceeding 26% annually—a rate that may be difficult to sustain given the compressed ROIC spread. The market is clearly pricing in aggressive expansion, yet the gap between the implied valuation and DCF-derived fair value suggests limited margin of safety at these multiples.
Risk assessment reveals a complex picture where high alpha generation clashes with insider sentiment and factor tilts. While the stock exhibits substantial Fama-French annualized alpha of 36.36%, indicating outperformance relative to standard risk factors, it carries a pronounced growth tilt evidenced by a negative HML value factor of -0.910. This exposure leaves the position vulnerable if market regimes shift toward value. Compounding this sensitivity is notable insider activity, with $133 million in net selling over the last 90 days, which contrasts sharply with the strong profitability signal from the RMW factor. Investors must weigh the impressive historical alpha and margin dominance against the elevated valuation multiple, growth-dependent returns, and recent executive distribution patterns.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 24% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 10.2% | 12.2% | 14.2% |
|---|---|---|---|
| 2% | $129 | $100 | $80 |
| 3% | $145 | $109 | $86 |
| 4% | $165 | $120 | $93 |
Center = base case. Green = >10% upside, Red = >10% downside vs $481.57.
Pre-computed DCF: WACC=12.2%, terminal growth 3%. Fair value $109 (-71.3%). Not investment advice.
Valuation Context
Currently trading 25% above its 5-year average P/E of 57.8x.
Price Chart with Moving Averages
Technical Setup
AI GeneratedBroadcom Inc. currently trades at $425.19 within the technology sector, presenting a scenario where high valuation multiples intersect with inherent market volatility for hardware and semiconductor leaders. The proximity of current price levels to recent historical peaks suggests that upward momentum may be driven more by fundamental earnings expectations than broad-based technical strength, creating a fragile structure susceptible to sharp corrections if revenue guidance misses analyst consensus. In such an environment, drawdown potential is amplified not merely by short-term sentiment shifts but by the sector's cyclical nature and sensitivity to global supply chain disruptions or demand softening in consumer electronics markets. The interplay between elevated price action and underlying volatility indicators implies that any deviation from current earnings trajectories could trigger rapid repricing, exposing long positions to significant downside risk without immediate support levels nearby. While the stock maintains a premium position relative to many peers, this strength often correlates with heightened beta during periods of macroeconomic uncertainty or tightening liquidity conditions typical in technology cycles. Consequently, the observed technical setup reflects a dynamic where structural growth narratives are tested against short-term liquidity constraints and valuation compression risks rather than establishing a stable floor for price appreciation.
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-03-23 | $0.6500 | 0.0% |
| 2025-12-22 | $0.6500 | +10.2% |
| 2025-09-22 | $0.5900 | 0.0% |
| 2025-06-20 | $0.5900 | 0.0% |
| 2025-03-20 | $0.5900 | 0.0% |
| 2024-12-23 | $0.5900 | +11.3% |
| 2024-09-19 | $0.5300 | +1.0% |
| 2024-06-24 | $0.5250 | 0.0% |
| 2024-03-20 | $0.5250 | 0.0% |
| 2023-12-19 | $0.5250 | +14.1% |
| 2023-09-20 | $0.4600 | 0.0% |
| 2023-06-21 | $0.4600 | 0.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
10-K Risk Factor Expansion
Word count of Item 1A (Risk Factors) across annual filings. Rising counts often signal new regulatory, competitive, or operational risks.
Smart Money Flow
Institutional 13F filings from top hedge funds. Positions updated quarterly from SEC EDGAR.
| Fund | Quarter | Shares Change | % Change | Action |
|---|---|---|---|---|
| DE Shaw | 2026-Q1 | +241,092 | +13.8% | Increased |
| Tiger Global | 2026-Q1 | +709,200 | +24.7% | Increased |
| Soros Fund Management | 2026-Q1 | +52,728 | +51.5% | Increased |
| Druckenmiller (Duquesne) | 2026-Q1 | +195,955 | +100.0% | New Position |
| Two Sigma Investments | 2026-Q1 | +36,000 | +211.8% | Increased |
| Millennium Management | 2026-Q1 | -207,100 | -6.8% | Decreased |
| Point72 Asset Mgmt | 2026-Q1 | -4,800 | -6.7% | Decreased |
| Citadel Advisors | 2026-Q1 | -1,540,100 | -15.7% | Decreased |
| Renaissance Technologies | 2026-Q1 | +792,908 | +89191.0% | Increased |
| Bridgewater Associates | 2026-Q1 | +669,640 | +57.4% | Increased |
| Two Sigma Investments | 2025-Q4 | +14,000 | +466.7% | Increased |
| Bridgewater Associates | 2025-Q4 | +320,349 | +37.9% | Increased |
Source: SEC 13F-HR filings. 13F data is delayed ~45 days after quarter end. Not investment advice.
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like SMH or VYM, the fund manager is mechanically forced to buy or sell AVGO shares regardless of Broadcom Inc.'s individual fundamentals. We estimate $243.1B of passive capital is structurally linked to AVGO through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Broadcom Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If Broadcom Inc. (AVGO) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NVIDIA Corp (NVDA) as the most exposed collateral stock, sharing 2 ETFs with AVGO. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 48 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
AVGO Ownership Dynamics
Passive funds hold 1 in every 8 AVGO shares, reducing daily market volatility.
Broadcom Inc. (AVGO) exerts measurable gravity on the passive index market, currently representing 8.4% of the VanEck Semiconductor ETF (SMH) and 8.0% of the Vanguard High Dividend Yield Index Fund ETF Shares (VYM). Across 38 tracked ETFs, approximately 626M shares (13.2% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest AVGO Exposure
Float lock-up computed from 38 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
AVGO Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Broadcom Inc. over the past year sits near $345.56 (18% of 252-day volume). The current price of $481.57 trades 39.4% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (18% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
AVGO Capital Efficiency
How efficiently does Broadcom Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Broadcom Inc. converts 78% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 1.2% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 505 | $416.79 | $210,478.95 |
| 2026-05-11 | 2,201 | $430.00 | $946,430 |
| 2026-05-07 | 208 | $425.44 | $88,491.52 |
| 2026-05-05 | 102 | $416.50 | $42,483 |
| 2026-05-04 | 2,135 | $421.28 | $899,432.8 |
| 2026-05-01 | 617 | $417.43 | $257,554.31 |
| 2026-04-30 | 18,284 | $405.45 | $7.4M |
| 2026-04-29 | 1,500 | $399.83 | $599,745 |
| 2026-04-28 | 13 | $418.20 | $5,436.6 |
| 2026-04-27 | 9,001 | $422.76 | $3.8M |
| 2026-04-24 | 11 | $419.94 | $4,619.34 |
| 2026-04-23 | 23,500 | $422.65 | $9.9M |
| 2026-04-22 | 70 | $402.17 | $28,151.9 |
| 2026-04-21 | 239 | $399.63 | $95,511.57 |
| 2026-04-20 | 189,377 | $406.54 | $77.0M |
| 2026-04-17 | 55 | $398.47 | $21,915.85 |
| 2026-04-16 | 1,600 | $396.72 | $634,752 |
| 2026-04-15 | 236 | $380.78 | $89,864.08 |
| 2026-04-14 | 1,390 | $379.75 | $527,852.5 |
| 2026-04-13 | 17,601 | $371.55 | $6.5M |
| 2026-04-10 | 300 | $354.91 | $106,473 |
| 2026-04-09 | 3,400 | $350.63 | $1.2M |
| 2026-04-08 | 1,405 | $333.97 | $469,227.85 |
| 2026-04-07 | 7,675 | $314.43 | $2.4M |
| 2026-04-06 | 8,438 | $314.55 | $2.7M |
| 2026-04-02 | 144 | $313.49 | $45,142.56 |
| 2026-04-01 | 71,905 | $309.51 | $22.3M |
| 2026-03-31 | 931 | $293.41 | $273,164.71 |
| 2026-03-27 | 1 | $309.42 | $309.42 |
| 2026-03-26 | 1,100 | $318.81 | $350,691 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Institutional Holdings (13F Filings)
Raw SEC 13F-HR filings from institutional investment managers. Shows exact share counts and portfolio values as reported to the SEC.
| Fund | Quarter | Shares | Value ($K) |
|---|---|---|---|
| Citadel Advisors | 2026-Q1 | 8,300,200 | $2,568,994,902K |
| Tiger Global | 2026-Q1 | 3,584,814 | $1,109,535,781K |
| Millennium Management | 2026-Q1 | 2,825,400 | $874,489,554K |
| DE Shaw | 2026-Q1 | 1,991,496 | $616,387,927K |
| Bridgewater Associates | 2026-Q1 | 1,835,380 | $568,068,464K |
| Renaissance Technologies | 2026-Q1 | 793,797 | $245,685,342K |
| Soros Fund Management | 2026-Q1 | 155,107 | $48,007,168K |
| Point72 Asset Mgmt | 2026-Q1 | 66,500 | $20,582,415K |
| Two Sigma Investments | 2026-Q1 | 53,000 | $16,404,030K |
| Druckenmiller (Duquesne) | 2026-Q1 | 195,955 | $60,650K |
| Citadel Advisors | 2025-Q4 | 9,840,300 | $3,405,727,830K |
| Millennium Management | 2025-Q4 | 3,032,500 | $1,049,548,250K |
| Tiger Global | 2025-Q4 | 2,875,614 | $995,250,005K |
| DE Shaw | 2025-Q4 | 1,750,404 | $605,814,824K |
| Bridgewater Associates | 2025-Q4 | 1,165,740 | $403,462,614K |
Source: SEC 13F-HR filings. Values reported in thousands. 13F data is delayed ~45 days after quarter end.
SEC Comment Letters
SEC correspondence with the company regarding their filings. Comment letters often flag disclosure deficiencies, accounting concerns, or material omissions.
Source: SEC EDGAR correspondence. Comment letters are public records of SEC staff review of company filings.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| TSM | 0.666 | 0.677 | Moderate |
| KYG254571055 | 0.641 | 0.603 | Moderate |
| CRDO | 0.641 | 0.603 | Moderate |
| NVDA | 0.613 | 0.640 | Moderate |
| FN | 0.590 | 0.609 | Moderate |
| VRT | 0.555 | 0.567 | Moderate |
| ETN | 0.545 | 0.505 | Moderate |
| PWR | 0.545 | 0.588 | Moderate |
| APH | 0.540 | 0.574 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare AVGO to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.